Rxivist logo

FcγRIIB I232T polymorphic change allosterically suppresses ligand binding

By Wei Hu, Yong Zhang, Xiaolin Sun, Liling Xu, Hengyi Xie, Zhanguo Li, Wanli Liu, Jizhong Lou, Wei Chen

Posted 24 Mar 2019
bioRxiv DOI: 10.1101/586487 (published DOI: 10.7554/eLife.46689)

FcγRIIB bindings to its ligand suppress immune cell activation. A single-nucleotide polymorphic (SNP) change, I232T, in the transmembrane (TM) domain of FcγRIIB loses its suppression function, which clinically associates with systemic lupus erythematosus (SLE). Previously, we reported that I232T tilts FcγRIIB's TM domain. In this study, combining with molecular dynamics simulations and single-cell FRET assay, we further revealed that such tilting by I232T unexpectedly bends the FcγRIIB's ectodomain towards plasma membrane to allosterically impede FcγRIIB's ligand association. We then used single-cell biomechanical assay to further find out that I232T also reduces two-dimensional in-situ binding affinities and association rates of FcγRIIB interacting with its ligands by three-folds. This allosteric regulation by a SNP provides an intrinsic molecular mechanism for functional loss of FcγRIIB-I232T in SLE patients.

Download data

  • Downloaded 294 times
  • Download rankings, all-time:
    • Site-wide: 150,122
    • In immunology: 4,621
  • Year to date:
    • Site-wide: 174,425
  • Since beginning of last month:
    • Site-wide: 130,706

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide